Effects of raloxifene on bone mineral density and biochemical markers of bone remodeling in postmenopausal women pre-treated with raloxifene or alendronate for one year.

被引：0
|
作者：
Brown, J
Ng, KW
Toss, G
Zhou, C
Wong, M
Draper, MW
机构：
[1] Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[4] Lilly Res Labs, Indianapolis, IN USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [1] Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis
    Johnell, O
    Scheele, WH
    Lu, YL
    Reginster, JY
    Need, AG
    Seeman, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03): : 985 - 992
  • [2] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
  • [3] Effects of raloxifene on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis and diabetes
    Lunar, L
    Serafin, M
    Da Silva, R
    Machado, M
    Gonzales, A
    Alfonzo, S
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S135 - S135
  • [4] Bone mineral density in postmenopausal women treated with raloxifene
    Danckers, LF
    Danckers, M
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 607 - 607
  • [5] Raloxifene effects on bone markers, bone mineral density, lipid profile and body composition in postmenopausal women
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S155 - S155
  • [6] Effects of raloxifene (RLX). Alendronate (ALN) and RLX plus ALN on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Stock, J
    Johnell, O
    Scheele, W
    Lu, Y
    Lakshmanan, M
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S176 - S176
  • [7] Effects of raloxifene (RLX), alendronate (ALN) and RLX plus ALN on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Johnell, O
    Scheele, W
    Lu, Y
    Lakshmanan, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S157 - S157
  • [8] Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women
    Komi, Janne
    Lankinen, Kari S.
    DeGregorio, Michael
    Heikkinen, Jorma
    Saarikoski, Seppo
    Tuppurainen, Marjo
    Halonen, Kaija
    Lammintausta, Risto
    Vaananen, Kalervo
    Ylikorkala, Olavi
    Erkkola, Risto
    JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (04) : 314 - 318
  • [9] Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women
    Janne Komi
    Kari S. Lankinen
    Michael DeGregorio
    Jorma Heikkinen
    Seppo Saarikoski
    Marjo Tuppurainen
    Kaija Halonen
    Risto Lammintausta
    Kalervo Väänänen
    Olavi Ylikorkala
    Risto Erkkola
    Journal of Bone and Mineral Metabolism, 2006, 24 : 314 - 318
  • [10] Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women
    Delmas, P. D.
    Davis, S. R.
    Hensen, J.
    Adami, S.
    van Os, S.
    Nijland, E. A.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (08) : 1153 - 1160
12345